The cardiovascular risk reduction seen with Rybelsus (14%) in SOUL is comparable to that seen in injectable semaglutide trials like SUSTAIN-6, which reported around 26% risk reduction, though direct comparisons should be interpreted cautiously
For researchers who are achieving strong results with tirzepatide alone and losing weight steadily without plateau, adding AOD 9604 is unnecessary
Cell Metab (2016) 24:55565
But NHS access is limited, private prescriptions are expensive, and these medications are not suitable for everyone
Kocsis K, Frank R, Szab J, Knapp L, Kis Z, Farkas T, Vcsei L, Toldi J (2016) Acetyl-l-carnitine restores synaptic transmission and enhances the inducibility of stable LTP after oxygen-glucose deprivation